XENCOR Trademark

Serial Number: 99885703

XENCOR is a trademark filed by Xencor, Inc. on June 15, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Trademark Classes

Class 1 - Chemicals

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

Xencor, Inc.

Suite 200
Pasadena, CA 91107

Entity Type: 03

Legal Representation

Attorney of Record

Virginia L. Carron

64 trademarks filed View all →

Correspondence Address

Virginia L. Carron Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.

901 New York Avenue, NW

Washington, DC 20001

United States

Trademark Details

Filing Date

June 15, 2026

Registration Date

Not Registered

First Use Anywhere

June 28, 2016

First Use in Commerce

June 28, 2016

Goods & Services

Biochemicals, namely, antibody-based biologics for research and development; biochemicals, namely, antibody-based biologics and polypeptides for use in the manufacture of pharmaceuticals for the treatment of oncological and autoimmune diseases and disorders and infectious diseases; Reagents for medical research

Product development consulting in the fields of biotechnology and pharmaceuticals; product development for others in the fields of biotechnology and pharmaceuticals; Research and development services in the field of medical preparations; Research and development of antibody-based biologics; Research and development in the field of pharmaceuticals

Pharmaceutical preparations, namely, antibody-based biologics and proteins for the treatment of oncological and autoimmune diseases and disorders and infectious diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of oncological and autoimmune diseases and disorders and infectious diseases; antibody-based biologics for medical purposes; Therapeutic antibody-based biologics for human use for the treatment of oncological and autoimmune diseases and disorders and infectious diseases